Li Hui, Liu Ruhui, Liu Junyan, Qu Yi
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), NHC Key Laboratory of Chronobiology, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Department of General Internal Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Biomolecules. 2024 Dec 10;14(12):1579. doi: 10.3390/biom14121579.
Nervous system diseases represent a significant global burden, affecting approximately 16% of the world's population and leading to disability and mortality. These conditions, encompassing both central nervous system (CNS) and peripheral nervous system (PNS) disorders, have substantial social and economic impacts. Metformin, a guanidine derivative derived from a plant source, exhibits therapeutic properties in various health conditions such as cancer, aging, immune-related disorders, polycystic ovary syndrome, cardiovascular ailments, and more. Recent studies highlight metformin's ability to cross the blood-brain barrier, stimulate neurogenesis, and provide beneficial effects in specific neurological disorders through diverse mechanisms. This review discusses the advancements in research on metformin's role and mechanisms in treating neurological disorders within both the central and peripheral nervous systems, aiming to facilitate further investigation, utilization, and clinical application of metformin in neurology.
神经系统疾病是一项重大的全球负担,影响着约16%的世界人口,并导致残疾和死亡。这些病症涵盖中枢神经系统(CNS)和外周神经系统(PNS)疾病,具有重大的社会和经济影响。二甲双胍是一种源自植物的胍类衍生物,在各种健康状况下如癌症、衰老、免疫相关疾病、多囊卵巢综合征、心血管疾病等均表现出治疗特性。最近的研究强调了二甲双胍穿越血脑屏障、刺激神经发生以及通过多种机制在特定神经系统疾病中产生有益作用的能力。本综述讨论了二甲双胍在中枢和外周神经系统治疗神经系统疾病中的作用和机制的研究进展,旨在促进二甲双胍在神经病学中的进一步研究、利用和临床应用。